MacroGenics, Inc. is focused on product development derived from in-house discoveries and in-licensed candidates in the areas of oncology, inflammation, and infectious diseases. The multi-faceted approach in developing both antibodies and vaccines provides a diversified strategy for creating proprietary immunotherapeutics in areas of unmet medical need.